These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2135009)

  • 41. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients.
    Karavelis A; Foroglou G; Selviaridis P; Fountzilas G
    Neurosurgery; 1996 Jul; 39(1):57-61; discussion 61-2. PubMed ID: 8805140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy.
    Lauretti GR; Gomes JM; Reis MP; Pereira NL
    J Clin Anesth; 1999 Dec; 11(8):663-8. PubMed ID: 10680109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management.
    Lauretti GR; Perez MV; Reis MP; Pereira NL
    J Clin Anesth; 2002 Mar; 14(2):83-6. PubMed ID: 11943517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.
    Glare P; Walsh D; Groh E; Nelson KA
    Am J Hosp Palliat Care; 2002; 19(5):343-50. PubMed ID: 12269781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
    Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U
    BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized study on oral administration of morphine and methadone in the treatment of cancer pain.
    Ventafridda V; Ripamonti C; Bianchi M; Sbanotto A; De Conno F
    J Pain Symptom Manage; 1986; 1(4):203-7. PubMed ID: 3537160
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck.
    Dennis GC; DeWitty RL
    Neurosurgery; 1990 Mar; 26(3):404-7; discussion 407-8. PubMed ID: 2320208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuing care for cancer pain relief with oral morphine solution. One-year experience in a regional cancer center.
    Vijayaram S; Ramamani PV; Chandrashekhar NS; Sudharshan R; Heranjal R; Lobo B; Obedullah D; Bhargava MK
    Cancer; 1990 Oct; 66(7):1590-5. PubMed ID: 1698528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myoclonic seizure activity with chronic high-dose spinal opioid administration.
    Parkinson SK; Bailey SL; Little WL; Mueller JB
    Anesthesiology; 1990 Apr; 72(4):743-5. PubMed ID: 1690960
    [No Abstract]   [Full Text] [Related]  

  • 51. Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF.
    Wong CS; Chang YC; Yeh CC; Huang GS; Cherng CH
    Can J Anaesth; 2002; 49(6):561-5. PubMed ID: 12067866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative analgesia with parenteral opioids: does continuous delivery utilizing a transdermal opioid preparation affect analgesic efficacy or patient safety?
    Sevarino FB; Paige D; Sinatra RS; Silverman DG
    J Clin Anesth; 1997 May; 9(3):173-8. PubMed ID: 9172021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Therapy refractory pain of malignant origin].
    Grunert P; Pendl G; Oztürk E
    Zentralbl Neurochir; 1989; 50(3-4):180-3. PubMed ID: 2642236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.
    Shimoyama N; Gomyo I; Teramoto O; Kojima K; Higuchi H; Yukitoshi N; Ohta E; Shimoyama M
    Jpn J Clin Oncol; 2015 Feb; 45(2):189-96. PubMed ID: 25378647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of chronic pain in advanced malignant disease by oral morphine (author's transl)].
    Brulé G; Belnat P; Apchin A; Domenge C; Voisin PM
    Nouv Presse Med; 1979 Oct; 8(39):3119-21. PubMed ID: 537869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is disease progression the major factor in morphine 'tolerance' in cancer pain treatment?
    Collin E; Poulain P; Gauvain-Piquard A; Petit G; Pichard-Leandri E
    Pain; 1993 Dec; 55(3):319-326. PubMed ID: 8121693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine.
    Kalman S; Osterberg A; Sörensen J; Boivie J; Bertler A
    Eur J Pain; 2002; 6(1):69-80. PubMed ID: 11888230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous morphine for rapid control of severe cancer pain.
    Harris JT; Suresh Kumar K; Rajagopal MR
    Palliat Med; 2003 Apr; 17(3):248-56. PubMed ID: 12725478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
    Kumar K; Kelly M; Pirlot T
    Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
    Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
    J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.